Level C· Early human research exploring benefitsProspective StudyEurope PMCOpen access

AB180. The relationship between fructose-1, 6-bisphosphatase and hypoxia related genes expression in clear cell renal cell carcinoma

Prospective Study with a reported sample of 123 on Hip, Systemic / IV, published in Transl Androl Urol (2015) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Transl Androl Urol (2015)
Reported sample size
123
Source database
Europe PMC
PMCID
PMC4708732

Abstract (original English)

Objective Fructose-1,6-bisphosphatase (FBP1) is often known as a rate-limiting enzyme in gluconeogenesis. Recently, its catalytic activity-independent function, repress hypoxia induced factor (HIF) in the nucleus, was identified. The aim of this study was to investigate the relationship between FBP1 and hypoxia related genes expression in clear cell renal cell carcinoma (ccRCC). Methods The expression levels of FBP1, HIF-1α, HIF-2α, erythropoietin (Epo) and carbonic anhydrase IX (CA9) were assessed by immunochemical staining in archival ccRCC paraffin blocks from 123 patients using the tissue microarray technique. The expression level of FBP1 was then correlated with clinicopathological factors and the expression levels of HIF-1α, HIF-2α, Epo and CA9. Results Clinicopathological factors including age, gender, TNM stage and Fuhrman grade were indifferent between the patients with low FBP1 expression and those with strong FBP1 expression in ccRCC. FBP1 expression level was positively correlated with the expression levels of HIF-1α (P=0.005) and Epo (P=0.010), but without correlation with the expression level of HIF-2α (P=0.123) and CA9 (P=0.513) in ccRCC tissues. Conclusions Our findings may be useful for recognizing the association between FBP1 and hypoxia related genes expression and understanding the mechanisms of ccRCC tumorigenesis.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research